Clinical Report: Development of Nomograms for Assessing Severe Pulmonary Hypertension
Overview
This study developed nomograms to predict severe pulmonary hypertension (PH) and survival in patients with chronic obstructive pulmonary disease (COPD). The models utilize non-invasive clinical metrics, demonstrating high predictive accuracy.
Background
Severe pulmonary hypertension is a significant complication of COPD, associated with increased mortality and adverse outcomes. Identifying reliable non-invasive predictors is crucial for timely intervention, especially given the limitations of invasive diagnostic methods like right heart catheterization. This study addresses the gap in predictive tools for assessing severe PH and mortality risk in COPD patients.
Data Highlights
Metric
Training Cohort C-index
Validation Cohort C-index
Severe PH Nomogram
0.906 (95% CI: 0.85–0.96)
0.93 (95% CI: 0.85–1.00)
Survival Nomogram
0.80 (95% CI: 0.71–0.89)
0.69 (95% CI: 0.52–0.86)
Key Findings
Nomograms were developed using non-invasive metrics to predict severe PH in COPD patients.
Key predictors for severe PH included peak SpO2, peak VO2/kg, peak HR, and PASP.
The C-index for the severe PH nomogram was 0.906 in the training cohort and 0.93 in the validation cohort.
Survival predictors included age, DLCO% predicted, and VE/VCO2 slope.
The survival nomogram showed a C-index of 0.80 in the training cohort and 0.69 in the validation cohort.
Calibration plots indicated good model performance in both cohorts.
Clinical Implications
The developed nomograms provide clinicians with a non-invasive tool to assess the risk of severe PH and predict survival in COPD patients. This can enhance clinical decision-making and facilitate timely therapeutic interventions.
Conclusion
The study presents effective nomogram models based on non-invasive metrics, offering valuable tools for predicting severe PH and survival in COPD patients.
